Skip to main content
. 2016 Mar 3;7(20):28935–28946. doi: 10.18632/oncotarget.7898

Figure 6. The effects of CB on RAF/MEK/ERK and PI3K/AKT/mTOR signaling in human NSCLC cell lines.

Figure 6

A. protein expression in RAF/MEK/ERK and AKT/MCL1 signaling determined by Western blot analysis after treatment with CB in H1299 cells. B. protein expression in AKT/mTOR and AKT/GSK3β signaling determined by Western blot analysis after treatment with CB in H1299 and A549 cells. All experiments were repeated three times. C. schematic representation of potential CB-induced apoptotic pathway in NSCLC cells.